Juan F. Alcala-Diaz

Dr. Juan F. Alcala-Diaz

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CMCarmen María Mariscal
Carmen María Mariscal
OROriol Alberto Rangel-Zuñiga
Oriol Alberto Rangel-Zuñiga
JAJuan F. Alcala-Diaz
Juan F. Alcala-Diaz
FGFrancisco Gomez-Delgado
Francisco Gomez-Delgado
PPPablo Pérez-Martínez
Pablo Pérez-Martínez
ACAntonio Camargo
Antonio Camargo
Intestinal microbiota changes are associated with the development of obesity. However, studies in humans have generated conflicting results due to high inter-individual heterogeneity in terms of diet, age, and hormonal factors, and the largely unexplored influence of gender. In this work, we aimed to identify differential gut microbiota signatures associated with obesity, as a function of gender and changes in body mass index (BMI). Differences in the bacterial community structure were analyzed by 16S sequencing in 39 men and 36 post-menopausal women, who had similar dietary background, matched by age and stratified according to the BMI. We observed that the abundance of the Bacteroides genus was lower in men than in women (P 33. In fact, the abundance of this genus decreased in men with an increase in BMI (P<0.001, Q<0.001). However, in women, it remained unchanged within the different ranges of BMI. We observed a higher presence of Veillonella (84.6% vs. 47.2%; X2 test P = 0.001, Q = 0.019) and Methanobrevibacter genera (84.6% vs. 47.2%; X2 test P = 0.002, Q = 0.026) in fecal samples in men compared to women. We also observed that the abundance of Bilophila was lower in men compared to women regardless of BMI (P = 0.002, Q = 0.041). Additionally, after correcting for age and sex, 66 bacterial taxa at the genus level were found to be associated with BMI and plasma lipids. Microbiota explained at P = 0.001, 31.17% variation in BMI, 29.04% in triglycerides, 33.70% in high-density lipoproteins, 46.86% in low-density lipoproteins, and 28.55% in total cholesterol. Our results suggest that gut microbiota may differ between men and women, and that these differences may be influenced by the grade of obesity. The divergence in gut microbiota observed between men and women might have a dominant role in the definition of gender differences in the prevalence of metabolic and intestinal inflammatory diseases.

1 October 2020 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
MCMarta Entrenas Castillo
Marta Entrenas Castillo
LCLuís Manuel Entrenas Costa
Luís Manuel Entrenas Costa
JBJosé Manuel Vaquero Barrios
José Manuel Vaquero Barrios
JAJuan F. Alcala-Diaz
Juan F. Alcala-Diaz
JLJosé López-Miranda
José López-Miranda
JGJosé Manuel Quesada Gomez
José Manuel Quesada Gomez

1 January 2016 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
CMCarmen María Mariscal
Carmen María Mariscal
MMMiguel Montes-Borrego
Miguel Montes-Borrego
OROriol Alberto Rangel-Zuñiga
Oriol Alberto Rangel-Zuñiga
JAJuan F. Alcala-Diaz
Juan F. Alcala-Diaz
FGFrancisco Gomez-Delgado
Francisco Gomez-Delgado
FPFrancisco Pérez-Jiménez
Francisco Pérez-Jiménez
Context: Gut microbiota, which acts collectively as a fully integrated organ in the host metabolism, can be shaped by long-term dietary interventions after a specific diet. Objective: The aim was to study the changes in microbiota after 1 year's consumption of a Mediterranean diet (Med diet) or a low-fat, high-complex carbohydrate diet (LFHCC diet) in an obese population. Design: Participants were randomized to receive the Med diet (35% fat, 22% monounsaturated) and the LFHCC diet (28% fat, 12% monounsaturated). Setting and Participants: The study was conducted in 20 obese patients (men) within the Coronary Diet Intervention With Olive Oil and Cardiovascular Prevention (CORDIOPREV) study, an ongoing prospective, randomized, opened, controlled trial in patients with coronary heart disease. Main Outcome Measure: We evaluated the bacterial composition and its relationship with the whole fecal and plasma metabolome. Results: The LFHCC diet increased the Prevotella and decreased the Roseburia genera, whereas the Med diet decreased the Prevotella and increased the Roseburia and Oscillospira genera (P = .028, .002, and .016, respectively). The abundance of Parabacteroides distasonis (P = .025) and Faecalibacterium prausnitzii (P = .020) increased after long-term consumption of the Med diet and the LFHCC diet, respectively. The changes in the abundance of 7 of 572 metabolites found in feces, including mainly amino acid, peptide, and sphingolipid metabolism, could be linked to the changes in the gut microbiota. Conclusions: Our results suggest that long-term consumption of the Med and LFHCC diets exerts a protective effect on the development of type 2 diabetes by different specific changes in the gut microbiota, increasing the abundance of the Roseburia genus and F. prausnitzii, respectively.

27 January 2015 in Diabetes
Verified
Journal Article
Open access
PDF file
OFOrla M. Finucane
Orla M. Finucane
CLClaire Lyons
Claire Lyons
AMAoife M. Murphy
Aoife M. Murphy
CRClare Reynolds
Clare Reynolds
RKRut Klinger
Rut Klinger
HRHelen M Roche
Helen M Roche
Saturated fatty acid (SFA) high-fat diets (HFDs) enhance interleukin (IL)-1β–mediated adipose inflammation and insulin resistance. However, the mechanisms by which different fatty acids regulate IL-1β and the subsequent effects on adipose tissue biology and insulin sensitivity in vivo remain elusive. We hypothesized that the replacement of SFA for monounsaturated fatty acid (MUFA) in HFDs would reduce pro-IL-1β priming in adipose tissue and attenuate insulin resistance via MUFA-driven AMPK activation. MUFA-HFD–fed mice displayed improved insulin sensitivity coincident with reduced pro-IL-1β priming, attenuated adipose IL-1β secretion, and sustained adipose AMPK activation compared with SFA-HFD–fed mice. Furthermore, MUFA-HFD–fed mice displayed hyperplastic adipose tissue, with enhanced adipogenic potential of the stromal vascular fraction and improved insulin sensitivity. In vitro, we demonstrated that the MUFA oleic acid can impede ATP-induced IL-1β secretion from lipopolysaccharide- and SFA-primed cells in an AMPK-dependent manner. Conversely, in a regression study, switching from SFA- to MUFA-HFD failed to reverse insulin resistance but improved fasting plasma insulin levels. In humans, high-SFA consumers, but not high-MUFA consumers, displayed reduced insulin sensitivity with elevated pycard-1 and caspase-1 expression in adipose tissue. These novel findings suggest that dietary MUFA can attenuate IL-1β–mediated insulin resistance and adipose dysfunction despite obesity via the preservation of AMPK activity.

1 January 2016 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
CMCarmen María Mariscal
Carmen María Mariscal
SGSonia Garcia-Carpintero
Sonia Garcia-Carpintero
JAJuan F. Alcala-Diaz
Juan F. Alcala-Diaz
FGFrancisco Gomez-Delgado
Francisco Gomez-Delgado
JDJavier Delgado-Lista
Javier Delgado-Lista
FPFrancisco Perez-Jimenez
Francisco Perez-Jimenez

1 July 2016 in American Heart Journal
Verified
Journal Article
Closed access
JDJavier Delgado-Lista
Javier Delgado-Lista
PPPablo Perez-Martinez
Pablo Perez-Martinez
AGAntonio Garcia-Rios
Antonio Garcia-Rios
JAJuan F. Alcala-Diaz
Juan F. Alcala-Diaz
APAna I. Perez-Caballero
Ana I. Perez-Caballero
CMCarmen Marin
Carmen Marin